VAERS Case Nos. 1199455, 1243487, 1307657 & 1388042: 17-Year-Olds Die After COVID Vaccination

Vaccine Adverse Effects

Case #1199455 received by VAERS on 4/12/2021: “Patient reported difficulty breathing and chest pain; suffered cardiac arrest and death” Date of COVID-19 Vaccination: 4/2/2021. Date of Death: 4/10/2021.

Case #1243487 received by VAERS on 4/22/2021: “Patient Committed Suicide with a firearm.” Date of COVID-19 Vaccination: 4/13/2021. Date of Death: 4/21/2021.

Case #1307657 received by VAERS on 5/11/2021: “Death by suicide.” Date of COVID-19 Vaccination: 4/19/2021. Date of Death: 4/23/2021.

Case #1388042 received by VAERS on 6/10/2021: “Patient had massive acute intracranial hemorrhage. Was found down in bathroom. In ED CT scan showed large intraventricular hemorrhage, EVD placed, patient progressed to massive brain swelling and infarctions, decompressive craniectomy, unable to control intracranial pressure, parents agreed to DNR status and patient is not expected to survive.” Date of COVID-19 Vaccination: 5/23/2021.


Established in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in U.S.-licensed vaccines. VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination. Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their attention.

VAERS is a passive reporting system, meaning it relies on individuals to send in reports of their experiences to CDC and FDA. VAERS is not designed to determine if a vaccine caused a health problem, but is especially useful for detecting unusual or unexpected patterns of adverse event reporting that might indicate a possible safety problem with a vaccine. This way, VAERS can provide CDC and FDA with valuable information that additional work and evaluation is necessary to further assess a possible safety concern.

Leave a Reply

Your email address will not be published. Required fields are marked *